Skyblue Healthcare Associates Ltd 07798022 false 2022-11-01 2023-10-31 2023-10-31 The principal activity of the company is that of management consultancy services Digita Accounts Production Advanced 6.30.9574.0 true 07798022 2022-11-01 2023-10-31 07798022 2023-10-31 07798022 bus:OrdinaryShareClass1 2023-10-31 07798022 core:CurrentFinancialInstruments 2023-10-31 07798022 core:CurrentFinancialInstruments core:WithinOneYear 2023-10-31 07798022 core:FurnitureFittingsToolsEquipment 2023-10-31 07798022 core:MotorVehicles 2023-10-31 07798022 bus:SmallEntities 2022-11-01 2023-10-31 07798022 bus:AuditExemptWithAccountantsReport 2022-11-01 2023-10-31 07798022 bus:FullAccounts 2022-11-01 2023-10-31 07798022 bus:SmallCompaniesRegimeForAccounts 2022-11-01 2023-10-31 07798022 bus:RegisteredOffice 2022-11-01 2023-10-31 07798022 bus:CompanySecretary1 2022-11-01 2023-10-31 07798022 bus:Director1 2022-11-01 2023-10-31 07798022 bus:OrdinaryShareClass1 2022-11-01 2023-10-31 07798022 bus:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 07798022 core:ComputerEquipment 2022-11-01 2023-10-31 07798022 core:FurnitureFittings 2022-11-01 2023-10-31 07798022 core:FurnitureFittingsToolsEquipment 2022-11-01 2023-10-31 07798022 core:MotorVehicles 2022-11-01 2023-10-31 07798022 core:EntitiesWithJointControlOrSignificantInfluenceOverReportingEntity 2022-11-01 2023-10-31 07798022 countries:AllCountries 2022-11-01 2023-10-31 07798022 2022-10-31 07798022 core:FurnitureFittingsToolsEquipment 2022-10-31 07798022 core:MotorVehicles 2022-10-31 07798022 2021-11-01 2022-10-31 07798022 2022-10-31 07798022 bus:OrdinaryShareClass1 2022-10-31 07798022 core:CurrentFinancialInstruments 2022-10-31 07798022 core:CurrentFinancialInstruments core:WithinOneYear 2022-10-31 07798022 core:FurnitureFittingsToolsEquipment 2022-10-31 07798022 core:MotorVehicles 2022-10-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 07798022

Skyblue Healthcare Associates Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 October 2023

 

Skyblue Healthcare Associates Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 7

 

Skyblue Healthcare Associates Ltd

Company Information

Director

Dr Suman Sandhu

Company secretary

Mr Jagmohan Singh Sandhu

Registered office

10 Prospect Place
Welwyn
Hertfordshire
AL6 9EW

Accountants

RS Partnership Ltd
Chartered Certified Accountants
10 Prospect Place
Welwyn
Hertfordshire
AL6 9EW

 

Skyblue Healthcare Associates Ltd

(Registration number: 07798022)
Balance Sheet as at 31 October 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

36,690

41,603

Current assets

 

Debtors

5

643,543

550,002

Cash at bank and in hand

 

716,603

1,083,106

 

1,360,146

1,633,108

Creditors: Amounts falling due within one year

6

(104,296)

(305,332)

Net current assets

 

1,255,850

1,327,776

Total assets less current liabilities

 

1,292,540

1,369,379

Provisions for liabilities

(9,173)

(7,905)

Net assets

 

1,283,367

1,361,474

Capital and reserves

 

Called up share capital

7

100

100

Retained earnings

1,283,267

1,361,374

Shareholders' funds

 

1,283,367

1,361,474

For the financial year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the director on 25 March 2024
 

.........................................
Dr Suman Sandhu
Director

 

Skyblue Healthcare Associates Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2023

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
10 Prospect Place
Welwyn
Hertfordshire
AL6 9EW

The principal place of business is:
6 Woburn Avenue
Bishops Stortford
Hertfordshire
CM23 4PW
England

These financial statements were authorised for issue by the director on 25 March 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

These financial statements are presented in Pounds Sterling (£), which is the Company’s functional
currency. All amounts have been rounded to the nearest pound, unless otherwise indicated.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

Skyblue Healthcare Associates Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2023

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Furniture, fittings & equipment

25% Reducing Balance

Furniture, fittings & equipment

33% Straight Line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Skyblue Healthcare Associates Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2023

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 2 (2022 - 2).

 

Skyblue Healthcare Associates Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2023

4

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost or valuation

At 1 November 2022

7,241

47,490

54,731

At 31 October 2023

7,241

47,490

54,731

Depreciation

At 1 November 2022

5,530

7,598

13,128

Charge for the year

923

3,990

4,913

At 31 October 2023

6,453

11,588

18,041

Carrying amount

At 31 October 2023

788

35,902

36,690

At 31 October 2022

1,711

39,892

41,603

5

Debtors

2023
£

2022
£

Trade debtors

143,908

284,991

Prepayments

158

290

Other debtors

499,477

264,721

643,543

550,002

6

Creditors

Creditors: amounts falling due within one year

2023
£

2022
£

Due within one year

Trade creditors

21,609

36,869

Taxation and social security

-

37,216

Accruals and deferred income

18,151

40,118

Other creditors

2,840

1,641

Corporation tax

19,115

107,132

Directors Loan Account

42,581

82,356

104,296

305,332

 

Skyblue Healthcare Associates Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 October 2023

7

Share capital

Allotted, called up and fully paid shares

 

2023

2022

 

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

         

8

Related party transactions

Summary of transactions with entities with joint control or significant interest

The directors of the company are also directors of Skyblue Estates Limited

At the year end debtors includes a balance due from Skyblue Estates Limited of £498,225 (2022 - £108,225). This loan is interest free.